Anticancer agent 31

• Description :

  Anticancer agent 31 is a 1,3-diphenylurea quinoxaline derivative, and a anticancer agent. Anticancer agent 31 exhibits antitumor acitvity by arresting cell cycle at S phase and inducing apoptosis[1].

• UNSPSC :

  12352005

• Target :

  Apoptosis

• Type :

  Reference compound

• Related Pathways :

  Apoptosis

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/anticancer-agent-31.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(NC1=CC=CC(CNC2=NC3=CC(F)=C(C=C3N=C2)F)=C1)NC4=CC=C(C=C4)OC5=CC=CC=C5

• Molecular Formula :

  C28H21F2N5O2

• Molecular Weight :

  497.50

• References & Citations :

  [1]Li GZ, et al. Synthesis and biological evaluation of novel 1,3-diphenylurea quinoxaline derivatives as potent anticancer agents. Med Chem Res 30,2021. 1496-1511.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2222930-72-3]